📰 Spatial Omics News
Spatial Omics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spatial Omics. Real-time updates on events, politics, business and more.
May 9, 2023
/PRNewswire/ -- On April 16th 2023, the first International Conference on Single-cell and Spatial Omics (TICSSO-1) has come to a grand conclusion. The...
March 2, 2023
Advances in Genome Biology and Technology delivers cutting-edge genomics news by day, holds beachside festivities (enlivened by Flo Rida’s “Low”) at night.
February 14, 2023
Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.
February 9, 2023
Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.
January 7, 2023
/PRNewswire/ -- The "Global Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments,...
January 5, 2023
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial...
November 3, 2022
Recent advancements in multiplexed profiling and tissue imaging methods have enabled the assessment of spatial heterogeneity in intact tissues; as a...
August 18, 2022
Spatial Omics Solutions Market to Reach $587.2 Million by 2030
January 14, 2022
The total award value including additional infrastructure funding exceeds $5M Concordia is now home to five additional Canada Research Chairs (CRCs
March 1, 2021
Spatial Genomics and Transcriptomics Market, 2030 News provided by Share this article Share this article ResearchAndMarkets.coms offering. Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030, progressing at a CAGR of 23.20%. The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays a...